LatestNFE Won't Halt Gas Deliveries Despite Payment Disputes, Genera PR Confirms
Cannabis

Florida DEP Issues Consent Order to Trulieve Over Wastewater Discharges at Monticello Cultivation Facility

TG Branfalt
Florida DEP Issues Consent Order to Trulieve Over Wastewater Discharges at Monticello Cultivation Facility
Summary

The Florida Department of Environmental Protection has entered a formal consent order with Trulieve Cannabis Corporation regarding wastewater discharges at its Capps Highway cultivation facility in Monticello. The action follows resident complaints about runoff containing reverse-osmosis reject water and condensate from dehumidifiers and HVAC systems. This enforcement action highlights ongoing environmental oversight of cannabis cultivation operations and their operational impacts on local water quality. Such regulatory measures are important for ensuring that medical marijuana production facilities maintain environmental standards while serving patients who depend on legal cannabis access for therapeutic purposes.

Originally published on

Ganjapreneur

By TG Branfalt

Read full article(opens in new tab)

Fetched: October 8, 2026 at 10:01 AM

Related News

More news you might be interested in

View all
Netherlands Faces Medical Cannabis Supply Gap During System Transition
Cannabis

Netherlands Faces Medical Cannabis Supply Gap During System Transition

The Netherlands is experiencing a critical supply disruption in its medical cannabis program as Bedrocan, the primary cultivator, has suspended payments amid an incomplete transition to a new regulatory model. While the Dutch government maintains current cannabis reserves for patients, official acknowledgment indicates existing stockpiles will not sustain operations until the new system becomes fully operational. To bridge this gap and ensure continuity of care for patients dependent on medical cannabis, authorities are arranging emergency imports to prevent treatment interruptions. This transition highlights the operational challenges governments face when restructuring medical cannabis infrastructure and the importance of coordinated supply chain planning.

1 hour ago
Revista Cáñamo
Italy Maintains Hemp Flower Ban Pending Constitutional Review in 2027
Cannabis

Italy Maintains Hemp Flower Ban Pending Constitutional Review in 2027

Italy's prohibition on hemp flowers will remain in effect while the Constitutional Court reviews the regulation, with hearings scheduled to begin in February 2027. The court will examine whether non-intoxicating cannabis products can legally be penalized under current law. This case has significant implications for patients seeking access to low-THC therapeutic hemp products and reflects ongoing European tensions between prohibition and medical access. The outcome could establish important precedent for distinguishing between intoxicating and non-intoxicating cannabis preparations in Italian law.

2 hours ago
Revista Cáñamo
Study: QR-Coded Cannabis Products Boost Consumer Confidence in Regulatory Protections
Cannabis

Study: QR-Coded Cannabis Products Boost Consumer Confidence in Regulatory Protections

A new study by Cannabis Public Policy Consulting found that 100% of cannabis consumers felt more protected by state regulators when products featured state-issued QR codes. Additionally, 91% reported that QR codes improved their understanding of consumer safeguards and quality standards, while 89% experienced increased confidence in their state's legal cannabis market. These findings underscore the importance of product traceability and transparency in building consumer trust within regulated cannabis markets. For patients using medical cannabis therapeutically, QR code verification systems provide critical assurance of product safety, potency accuracy, and regulatory compliance.

3 hours ago
Ganjapreneur
New York Approves Medical Cannabis Trial Using THC Oral Solution for Sciatica Pain
Cannabis
Chronic Pain

New York Approves Medical Cannabis Trial Using THC Oral Solution for Sciatica Pain

The New York Cannabis Control Board has approved a groundbreaking clinical trial investigating VER-01, an oral THC solution, for treating chronic pain associated with lumbosacral radiculopathy (sciatica). This first-of-its-kind research represents a significant step in evaluating cannabis-derived therapeutics for neuropathic pain conditions. The study addresses a substantial patient population suffering from sciatica-related chronic pain who may benefit from alternative treatment options. This approval underscores growing regulatory recognition of cannabinoid-based medicines and their potential therapeutic applications in pain management.

3 hours ago
Ganjapreneur